ACM
HRMY icon

Argent Capital Management’s Harmony Biosciences HRMY Stock Holding History

Argent Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$647K Buy
+16,468
New +$636K 0.02% 146

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Argent Capital Management's HRMY Position: Q3 2026 in Review

Argent Capital Management opened a new position in Harmony Biosciences (HRMY) in Q3 2026: 16,468 shares worth $647K. The stake represents 0.02% of the portfolio and ranks #146 among its holdings.

9 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Argent Capital Management held 16,468 shares of Harmony Biosciences worth $647K as of Q3 2026.
  • Harmony Biosciences was a new Argent Capital Management position in Q3 2026.
  • Harmony Biosciences made up 0.02% of Argent Capital Management's portfolio in Q3 2026, its #146 holding.
  • 9 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Argent Capital Management's 13F filing for Q3 2026, filed 5 Oct 2026.